wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27302122-0A76CF55-4B49-4B10-8CE1-06C6E678C123
Q27302122-0A76CF55-4B49-4B10-8CE1-06C6E678C123
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302122-0A76CF55-4B49-4B10-8CE1-06C6E678C123
Predictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft models
P2860
Q27302122-0A76CF55-4B49-4B10-8CE1-06C6E678C123
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302122-0A76CF55-4B49-4B10-8CE1-06C6E678C123
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f561c5877a01bfd85b73d88554690a7fc983c1b
P2860
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun